A multicenter study has found the cost savings of the two leading non-invasive methods for detecting coronary artery disease (CAD) varies based on the patient's heart history. The study found that patients who underwent coronary computed tomographic angiography (CCTA), without a prior diagnosis of CAD, incurred costs $603 lower (per patient average) than those who underwent myocardial perfusion imaging (MPI or SPECT). Both groups had equal clinical outcomes. However, patients with known CAD who underwent MPI incurred healthcare costs $2,451 lower (per patient average) than CCTA patients with equal clinical outcomes. These results suggest that CCTA may be a cost-efficient alternative in patients without a prior CAD diagnosis.
source: MedicalNewsToday
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment